METHOD OF INCREASING BIOAVAILABILITY OF ALENDRONATE OR OTHER BIS-PHOSPHONATE BY PREDOSE ADMINISTRATION OF VITAMIN D DERIVATIVE

Details for Australian Patent Application No. 2003300984 (hide)

Owner TEVA PHARMACEUTICAL INDUSTRIES LTD.

Inventors FLASHNER-BARAK, Moshe; LERNER, Itzhak, E.; ROSENBERGER, Vered

Pub. Number AU-A-2003300984

PCT Number PCT/US2003/0401

PCT Pub. Number WO2004/058235

Priority 60/433,685 16.12.02 US; 60/460,206 02.04.03 US

Filing date 16 December 2003

Wipo publication date 22 July 2004

International Classifications

A61K 031/00

Event Publications

27 May 2004 Complete Application Filed

  Priority application(s): 60/433,685 16.12.02 US; 60/460,206 02.04.03 US

26 August 2004 Application Open to Public Inspection

  Published as AU-A-2003300984

22 September 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003300985-POLYMER LINK HYBRID STENT

2003300983-ETHOXYLATED ALKYLPHOSPHATE ESTERS AS PLUGMAKER PROCESSING AIDS